Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | AMGN | VRTX | BMY | GILD |
| Company | Biontech Se ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 108.85 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 111.08 | 319.52 | 498.00 | 56.18 | 90.29 |
| Low | 108.35 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 109.89 | 318.23 | 498.98 | 56.12 | 90.22 |
| Change | +0.92 | +1.32 | +26.18 | +0.67 | +0.38 |
| % Change | +0.84% | +0.42% | +5.54% | +1.21% | +0.42% |
| Volume | 177,342 | 501,863 | 752,142 | 3,557,455 | 1,562,573 |
| 20-Day Average Volume | 645,725 | 1,672,215 | 1,022,744 | 8,407,323 | 5,033,236 |
| Previous Close | 108.97 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 113.93 | 319.71 | 478.77 | 53.24 | 87.52 |
| 20-Day Raw Stochastic | 20.79% | 45.42% | 95.57% | 97.65% | 91.60% |
| 20-Day Relative Strength | 48.63% | 47.85% | 59.89% | 64.36% | 69.67% |
| Weighted Alpha | -0.93 | +16.64 | +31.76 | +18.67 | +27.53 |
| Today's Opinion | 56% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.36% since 10/29/24 | +0.97% since 10/29/24 | +5.70% since 10/29/24 | +6.83% since 10/29/24 | +2.36% since 10/29/24 |
| Low | 107.19 on 11/04/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 114.57 on 10/30/24 | 323.40 on 10/31/24 | 498.00 on 11/05/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | -10.19% since 10/04/24 | -0.19% since 10/04/24 | +9.20% since 10/04/24 | +3.94% since 10/04/24 | +6.58% since 10/04/24 |
| Low | 107.19 on 11/04/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 124.00 on 10/07/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | +40.61% since 08/05/24 | -1.90% since 08/05/24 | +4.25% since 08/05/24 | +17.85% since 08/05/24 | +20.49% since 08/05/24 |
| Low | 76.84 on 08/06/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 131.49 on 09/17/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | +18.83% since 05/03/24 | +2.49% since 05/03/24 | +23.96% since 05/03/24 | +27.49% since 05/03/24 | +39.18% since 05/03/24 |
| Low | 76.53 on 08/05/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 131.49 on 09/17/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 25,909,362 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 237,766 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 4,133,300,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 1,006,860,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 138,600,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -869,920,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.26 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.81 on 11/04/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/04/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | 3.084 on 06/02/22 | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 06/02/22 | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |